JP2024539123A5 - - Google Patents
Info
- Publication number
- JP2024539123A5 JP2024539123A5 JP2024523575A JP2024523575A JP2024539123A5 JP 2024539123 A5 JP2024539123 A5 JP 2024539123A5 JP 2024523575 A JP2024523575 A JP 2024523575A JP 2024523575 A JP2024523575 A JP 2024523575A JP 2024539123 A5 JP2024539123 A5 JP 2024539123A5
- Authority
- JP
- Japan
- Prior art keywords
- aav
- aavhu
- aavrh
- approximately
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163271487P | 2021-10-25 | 2021-10-25 | |
| US63/271,487 | 2021-10-25 | ||
| PCT/IB2022/060189 WO2023073526A1 (en) | 2021-10-25 | 2022-10-24 | Methods for improving adeno-associated virus (aav) delivery |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024539123A JP2024539123A (ja) | 2024-10-28 |
| JP2024539123A5 true JP2024539123A5 (cg-RX-API-DMAC7.html) | 2025-10-31 |
Family
ID=84283163
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024523575A Pending JP2024539123A (ja) | 2021-10-25 | 2022-10-24 | アデノ随伴ウイルス(aav)送達を改善する方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20250235554A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4422613A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024539123A (cg-RX-API-DMAC7.html) |
| CN (1) | CN118043039A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023073526A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024071362A1 (ja) * | 2022-09-30 | 2024-04-04 | 国立大学法人東京医科歯科大学 | 神経系送達促進剤 |
| WO2025101959A1 (en) * | 2023-11-08 | 2025-05-15 | Renbio, Inc. | Plasmid dna constructs for peptide hormone expression |
| WO2025250454A1 (en) * | 2024-05-28 | 2025-12-04 | University Of Rochester | Adeno-associated viruses evolved to specifically target human glial progenitor cells in vivo |
| CN118743768A (zh) * | 2024-06-13 | 2024-10-08 | 浙江大学 | 一种血小板-aav包装复合体及其制备方法和应用 |
| WO2026006766A1 (en) | 2024-06-27 | 2026-01-02 | Applied Cognition, Inc. | Compositions, formulations, and methods of treating neurodegenerative diseases |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5139941A (en) | 1985-10-31 | 1992-08-18 | University Of Florida Research Foundation, Inc. | AAV transduction vectors |
| WO1998033917A1 (en) | 1994-11-14 | 1998-08-06 | The Ludwig Institute For Cancer Research | Vascular endothelial growth factor c (vegf-c) protein and gene, mutants thereof, and uses thereof |
| US6001650A (en) | 1995-08-03 | 1999-12-14 | Avigen, Inc. | High-efficiency wild-type-free AAV helper functions |
| US6410300B1 (en) | 1998-01-12 | 2002-06-25 | The University Of North Carolina At Chapel Hill | Methods and formulations for mediating adeno-associated virus (AAV) attachment and infection and methods for purifying AAV |
| ES2932278T3 (es) | 2004-06-01 | 2023-01-17 | Genzyme Corp | Composiciones y métodos para prevenir la agregación del vector AAV |
| PT2548560E (pt) | 2005-06-23 | 2015-09-22 | Isis Pharmaceuticals Inc | Composições e métodos de modulação da excisão-união de smn2 |
| US9415121B2 (en) | 2008-12-19 | 2016-08-16 | Nationwide Children's Hospital | Delivery of MECP2 polynucleotide using recombinant AAV9 |
| KR20220084437A (ko) | 2009-06-17 | 2022-06-21 | 바이오젠 엠에이 인코포레이티드 | 대상에게서 smn2 스플라이싱을 조정하기 위한 조성물 및 방법 |
| US9901650B2 (en) * | 2013-02-21 | 2018-02-27 | University Of Rochester | Methods for evaluating brain-wide paravascular pathway for waste clearance function and methods for treating neurodegenerative disorders based thereon |
| RS63942B1 (sr) | 2013-08-27 | 2023-02-28 | Res Inst Nationwide Childrens Hospital | Proizvodi i postupci za lečenje amiotrofične lateralne skleroze |
| EP3564379A1 (en) | 2013-09-13 | 2019-11-06 | California Institute of Technology | Selective recovery |
| EP3632923A1 (en) | 2015-01-16 | 2020-04-08 | Voyager Therapeutics, Inc. | Central nervous system targeting polynucleotides |
| AU2016366549B2 (en) | 2015-12-11 | 2022-11-10 | California Institute Of Technology | Targeting peptides for directing adeno-associated viruses (AAVs) |
| EP4585229A3 (en) | 2017-11-08 | 2026-01-14 | Novartis AG | Means and method for preparing viral vectors and uses of same |
| WO2019222329A1 (en) | 2018-05-15 | 2019-11-21 | Voyager Therapeutics, Inc. | Compositions and methods for delivery of aav |
| WO2019222444A2 (en) | 2018-05-16 | 2019-11-21 | Voyager Therapeutics, Inc. | Directed evolution |
| US20210207167A1 (en) | 2018-05-16 | 2021-07-08 | Voyager Therapeutics, Inc. | Aav serotypes for brain specific payload delivery |
| EP3830107A2 (en) | 2018-08-03 | 2021-06-09 | Voyager Therapeutics, Inc. | Aav variants with enhanced tropism |
| KR20210100086A (ko) * | 2018-10-04 | 2021-08-13 | 유니버시티 오브 로체스터 | 혈장 오스몰농도 조작에 의한 글림프 전달의 개선 |
-
2022
- 2022-10-24 JP JP2024523575A patent/JP2024539123A/ja active Pending
- 2022-10-24 CN CN202280063874.4A patent/CN118043039A/zh active Pending
- 2022-10-24 US US18/703,559 patent/US20250235554A1/en active Pending
- 2022-10-24 WO PCT/IB2022/060189 patent/WO2023073526A1/en not_active Ceased
- 2022-10-24 EP EP22800804.1A patent/EP4422613A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20260139274A1 (en) | Gene therapy for juvenile batten disease | |
| US20240123003A1 (en) | Gene therapies for lysosomal disorders | |
| Huang et al. | Challenges in adeno-associated virus-based treatment of central nervous system diseases through systemic injection | |
| JP2020533959A5 (cg-RX-API-DMAC7.html) | ||
| JP6417322B2 (ja) | 遺伝子治療ベクターの広範な遺伝子送達 | |
| JP2025179046A5 (cg-RX-API-DMAC7.html) | ||
| AU2023202598B2 (en) | Intrathecal delivery of recombinant Adeno-associated virus encoding Methyl-CpG binding protein 2 | |
| JP2016514152A (ja) | アデノ随伴ウイルスベクターおよびその使用の方法 | |
| JP2023514242A5 (cg-RX-API-DMAC7.html) | ||
| US12486518B2 (en) | Bicistronic AAV vectors encoding hexosaminidase alpha and beta-subunits and uses thereof | |
| US20230310654A1 (en) | Gene therapies for lysosomal disorders | |
| JP2024539123A (ja) | アデノ随伴ウイルス(aav)送達を改善する方法 | |
| JP2025518052A (ja) | Xlmtmを処置するための組成物 | |
| WO2025019295A2 (en) | Renal pelvic injection for drug delivery to the kidney | |
| JP2022545378A5 (cg-RX-API-DMAC7.html) | ||
| WO2023169115A1 (zh) | 一种神经系统高亲和性的aav载体及其应用 | |
| JP2024530050A5 (cg-RX-API-DMAC7.html) | ||
| JP2025512709A5 (cg-RX-API-DMAC7.html) | ||
| JP2024515629A5 (cg-RX-API-DMAC7.html) | ||
| US20250250566A1 (en) | Gene silencing by recombinant aav-amirna in alexander disease | |
| JP2025510150A5 (cg-RX-API-DMAC7.html) | ||
| TW202432190A (zh) | 投藥途徑 | |
| WO2025157137A1 (zh) | Aav载体、载体组合物、嵌合载体和治疗或预防sma的方法 | |
| TW202434729A (zh) | 含有星狀細胞導向啟動子構築體之合成核酸及其使用方法 | |
| JP2024515623A (ja) | 髄腔内送達によってピット・ホプキンス症候群を治療するためのメチル-cpg結合タンパク質2をコードする組換えアデノ随伴ウイルス |